Corporate Glenmark Pharmaceuticals Limited March 21, 2026 Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. |SUBJECT: Press Release Post navigation Poonawalla Fincorp Limited Poonawalla Fincorp Limited Related Posts Syrma SGS Technology Limited Reconciliation of Share Capital Audit Report as per Regulation 76 of SEBI (Depositories and Participants)… April 9, 2026 Ester Industries Limited ESTER INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2026… May 8, 2026 Tanla Platforms Limited Tanla Platforms Limited has informed the Exchange regarding Outcome of Board Meeting held on null… April 25, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Syrma SGS Technology Limited Reconciliation of Share Capital Audit Report as per Regulation 76 of SEBI (Depositories and Participants)… April 9, 2026
Ester Industries Limited ESTER INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2026… May 8, 2026
Tanla Platforms Limited Tanla Platforms Limited has informed the Exchange regarding Outcome of Board Meeting held on null… April 25, 2026
